Panacea Pharmaceuticals, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 8247
 
 
 
C07K PEPTIDES 3133
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0036,424 IMMUNE SYSTEM ENHANCING IMMUNOTHERAPY FOR THE TREATMENT OF CANCERMay 09, 17Feb 08, 18[A61K]
2017/0072,034 THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)Jun 08, 16Mar 16, 17[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9744223 Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)Nov 06, 13Aug 29, 17[A61K, C12N, C07K]
7605133 Isolated peptides to treat alpha-synuclein diseasesJul 30, 04Oct 20, 09[A61K, C07K]
7521479 Methods of treating prion disease in mammalsApr 16, 01Apr 21, 09[A61K, A01N]
7456179 Methods of treating ischemic related conditionsApr 30, 04Nov 25, 08[A61K]
6835370 Diagnosis and treatment of malignant neoplasmsMay 17, 01Dec 28, 04[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0151,339 Treatment for Chemotherapy-Induced Peripheral NeuropathyAbandonedFeb 04, 16Jun 02, 16[A61K]
2016/0077,098 RECOVERY OF ASPARTYL (ASPARAGINYL) BETA HYDROXYLASE (HAAH) FROM AN EXOSOMAL FRACTION OF HUMAN SERA FROM CANCER PATIENTSAbandonedSep 14, 15Mar 17, 16[G01N]
2010/0172,832 DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMSAbandonedDec 21, 09Jul 08, 10[A61K]
2009/0298,097 METHODS FOR THE DIAGNOSIS OF LUNG CANCERAbandonedJul 17, 08Dec 03, 09[G01N]
2009/0286,799 METHODS FOR THE TREATMENT OF BRAIN EDEMAAbandonedMay 18, 09Nov 19, 09[A61K, A61P]
2009/0155,289 FURIN-CLEAVABLE PEPTIDE LINKERS FOR DRUG-LIGAND CONJUGATESAbandonedNov 03, 08Jun 18, 09[A61K, C07K]
2008/0182,853 Methods of neuroprotection by cyclin-dependent kinase inhibitionAbandonedDec 14, 07Jul 31, 08[A61K, A61P]
2008/0124,718 METHODS OF DIAGNOSING, PREDICTING THERAPEUTIC EFFICACY AND SCREENING FOR NEW THERAPEUTIC AGENTS FOR LEUKEMIAAbandonedJan 29, 07May 29, 08[C12Q]
2008/0039,471 Composition and method to inhibit tissue plasminogen activator (tPA) -potentiated neurotoxicityAbandonedAug 14, 06Feb 14, 08[A61K]
2007/0179,147 Methods of treating and preventing Alzheimer's diseaseAbandonedJan 27, 06Aug 02, 07[A61K]
2006/0194,810 Methods of treating ischemic related conditionsAbandonedNov 18, 05Aug 31, 06[A61K]
2005/0113,329 Diagnosis and treatment of malignant neoplasmsAbandonedDec 23, 04May 26, 05[C07H, A61K]
6780971 Compositions for inhibiting the aggregation pathway of .alpha.-synucleinExpiredJul 09, 01Aug 24, 04[A61K, A01K, C07K]
2004/0146,945 Olfactory neuron cultures and method of making and using the sameAbandonedApr 23, 03Jul 29, 04[G01N]
2004/0146,946 Olfactory neuron cultures and method of making and using the sameAbandonedApr 23, 03Jul 29, 04[G01N]
2002/0177,614 Methods for treating nuerodegenerative diseases including alzheimer'sAbandonedMar 23, 01Nov 28, 02[A61K]
2002/0016,284 Olfactory neuron cultures and method of making and using the sameAbandonedJul 09, 01Feb 07, 02[A61K, C12Q]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.